Skip to main content
. 2012 May 27;4(5):158–168. doi: 10.4254/wjh.v4.i5.158

Table 1.

Immune dysfunction in cirrhotic patients

Natural barriers Fragile, thin and/or edematous skin Alteration of gastrointestinal motility, mucosal permeability and bacterial flora ↑ Gastrointestinal mucosal ulcerations
Hepatic RES activity Portosystemic shunting Kupffer cells – ↓ number, impaired function
Cellular defense mechanisms RES – ↓ activation, ↓ chemotaxis, ↓ phagocytosis, ↓ production of pro-inflammatory cytokines PMN – ↓ lifespan, ↓ intracellular killing activity, ↓ phagocytosis, ↓ chemotaxis
Serum factors ↓ Complement levels (C3, C4, CH50) ↓ Opsonic activity ↓ Protein C activity
Iatrogenic and treatment-related factors Invasive procedure and catheters Medications: immunosuppressive agents, proton pump inhibitors
Other compelling factors Malnutrition Alcohol drinking

RES: Reticuloendothelial system; PMN: Polymorphonuclear neutrophil.